Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free AMRX Stock Alerts

Amneal Pharmaceuticals (AMRX) Earnings Date, Estimates & Call Transcripts

Amneal Pharmaceuticals logo
$13.64 +0.03 (+0.18%)
As of 11:02 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Amneal Pharmaceuticals Earnings Summary

Amneal Pharmaceuticals announced Q1 2026 & M&A announcement earnings on April 22, 2026, reporting an EPS of $0.26, which topped analysts' consensus estimates of $0.15 by $0.11. Quarterly revenue was reported to be $723 million, above analyst estimates of $709.79 million. With a trailing EPS of $0.38 and a P/E Ratio of 35.91, Amneal Pharmaceuticals' earnings are expected to grow 18.48% next year, from $0.92 to $1.09 per share.

Consensus EPS
(Apr. 22)
$0.15
Actual EPS
(Apr. 22)
$0.26 Beat By $0.11
Actual Revenue
(Apr. 22)
$723.00M

Q1 2026 & M&A announcement Earnings Resources

Slide Deck

Amneal Pharmaceuticals' Q1 2026 & M&A announcement Slide DeckFull Screen Slide Deck
Powered by Quartr
Get Amneal Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amneal Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

AMRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Amneal Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate
$0.92 EPS
Next Year EPS Consensus Estimate
$1.09 EPS

Amneal Pharmaceuticals Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/22/2026Q1 2026 & M&A announcement$0.15$0.26+$0.11$0.19$709.79M$723.00M
10/30/2025Q3 2025$0.12$0.17+$0.05$0.01-$784.51M
8/5/2025Q2 2025$0.17$0.23+$0.06$0.07-$724.51M
7/21/2025Q2 2025-$0.21---$695.42M
5/2/2025Q1 2025$0.14$0.19+$0.05$0.04$714.78M$695.42M
2/28/2025Q4 2024$0.15$0.12 -$0.03-$0.10$708.21M$730.52M
8/9/2024Q2 2024$0.11$0.15+$0.04$0.28$657.43M$701.78M

Data powered by Fiscal.ai.

Amneal Pharmaceuticals Earnings - Frequently Asked Questions

Amneal Pharmaceuticals (NASDAQ:AMRX) last announced its quarterly earning data on Wednesday, April 22, 2026. Learn more on AMRX's earnings history.

Amneal Pharmaceuticals updated its first quarter 2026 earnings guidance on Wednesday, April, 22nd. The company provided EPS guidance of 0.270-0.270 for the period, compared to the consensus earnings per share estimate of 0.160. The company issued revenue guidance of $723.0 million-$723.0 million, compared to the consensus revenue estimate of $715.0 million.

In the previous quarter, Amneal Pharmaceuticals (NASDAQ:AMRX) reported $0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $0.15 by $0.11. Learn more on analysts' earnings estimate vs. AMRX's actual earnings.

The conference call for Amneal Pharmaceuticals' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Amneal Pharmaceuticals' latest earnings report can be read online.
Read Transcript

Amneal Pharmaceuticals (NASDAQ:AMRX) has a recorded annual revenue of $3.02 billion.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a recorded net income of $72.06 million. AMRX has generated $0.38 earnings per share over the last four quarters.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a trailing price-to-earnings ratio of 35.91 and a forward price-to-earnings ratio of 14.83.

Amneal Pharmaceuticals' earnings are expected to grow from $0.92 per share to $1.09 per share in the next year, which is a 18.48% increase.

Related Companies
Earnings Tools

This page (NASDAQ:AMRX) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel